about
Aminophylline for bradyasystolic cardiac arrest in adultsAminophylline for bradyasystolic cardiac arrest in adultsAminophylline for bradyasystolic cardiac arrest in adultsMolecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1)Cloning of human adenosine kinase cDNA: sequence similarity to microbial ribokinases and fructokinasesLow-dose adenosine stress echocardiography: detection of myocardial viabilityA randomized controlled trial of intravenous aminophylline for atropine-resistant out-of-hospital asystolic cardiac arrestAdenosine-mediated hypotension in in vivo guinea-pig: receptors involved and role of NOEvidence for the presence of A(1) adenosine receptors in the aorta of spontaneously hypertensive ratsAssessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonanceThe role of adenosine in the early respiratory and cardiovascular changes evoked by chronic hypoxia in the ratImmunocytochemical demonstration of the equilibrative nucleoside transporter rENT1 in rat sinoatrial nodePhysiological assessment of coronary artery disease and myocardial viability in ischemic syndromes using adenosine echocardiography.Transgenic overexpression of cardiac A(1) adenosine receptors mimics ischemic preconditioning.Dominance of G(s) in doubly G(s)/G(i)-coupled chimaeric A(1)/A(2A) adenosine receptors in HEK-293 cells.PHOTOLABILE A1-ADENOSINE RECEPTOR AGONISTS AS "CAGED" ELECTROPHYSIOLOGICAL PROBESCloning and expression of a bovine adenosine A1 receptor cDNA.The allosteric enhancer PD81,723 increases chimaeric A1/A2A adenosine receptor coupling with GsFunctional studies in atrium overexpressing A1-adenosine receptors.Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemiaClinical features of adenosine sensitive syncope and tilt induced vasovagal syncope.Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.Role of beta-arrestin1/ERK MAP kinase pathway in regulating adenosine A1 receptor desensitization and recovery.Electrophysiological basis for the use of adenosine in the diagnosis and treatment of cardiac arrhythmias.A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia.Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.A(2A) adenosine receptors in human peripheral blood cellsRadiofrequency catheter ablation of atrial fibrillation initiated by pulmonary vein ectopic beats.Ischemic preconditioning: the endogenous power--a review of the literature.Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma.NEW BASE-ALTERED ADENOSINE ANALOGUES: SYNTHESIS AND AFFINITY AT ADENOSINE A1 and A2A RECEPTORS.Adenosine receptor regulation of coronary blood flow in Ossabaw miniature swineAdenosine receptors and vascular inflammationCaffeine and stress: implications for risk, assessment, and management of hypertension.Cardiac protection by pharmacological modulation of inflammation.Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis.Effects of mitoxantrone on action potential and membrane currents in isolated cardiac myocytes.The adverse events and hemodynamic effects of adenosine-based cardiac MRIAdenosine induced transient cardiac standstill in catheter interventional procedures for congenital heart disease.Matching coronary blood flow to myocardial oxygen consumption.
P2860
Q24187691-9ED47019-036C-4410-88F4-D125BD27F7DBQ24200423-C50F2610-0194-4222-BF88-A7AFAFD6AE6BQ24243126-D3EF0D43-1E76-42BC-A069-A8AB2637C6CCQ24317366-D105D21D-EB06-4FEE-825B-9B2CA3008CCFQ24567559-9B61FEDB-3D73-43E8-954D-B5C0191404B9Q24802516-40B7A165-E126-4105-B3D8-02768DDD6414Q28180206-9E6C1B57-A8B9-404F-84CF-7BC128B0B5EEQ28362050-44E200D9-0A47-4176-9FA9-B54AE992E78AQ28366067-7D0E6108-35EA-42C7-A36A-311460D6D1F1Q28387402-9351A74D-E765-4005-B19C-BCC42B4DF0EDQ28565614-4B2ADCC4-3C9A-42CE-9AFE-4FDCFED13938Q28567094-66D9367B-3094-4C3D-AFC0-2C5A679A125DQ30303745-75C87622-F5FE-4B28-B2FA-CC1577A00AC8Q30306098-D1C19184-F7A1-4F9A-BD22-18CC5DEBF466Q30306324-ECAB100D-AB48-47BF-81E3-B182FFE5B648Q30384330-E9803370-7FC5-4EAA-9218-5EDD8C2B22C9Q30434970-4471B69C-4AF1-46AA-90CD-E7A837F24064Q30439117-491AE4C3-23F3-4C08-9E55-302410FAD8A5Q30443941-41ED6EFD-6143-4C3B-A7F0-6666FF61C8D0Q30454370-0173EAB4-31E5-4809-8762-5201A4625139Q33145197-129B3E7D-2AFA-4A09-9661-11F6EED8CCFEQ33403252-FAAF3FFD-F0E8-4236-93CD-B9F759EC0FF6Q33589255-A0F55A3F-F165-435E-8945-0F537E9AE2F9Q33610256-DD219148-CE6E-4E52-9C3E-CCD949D8DB18Q33797566-51ADF50B-87FD-430A-97F3-DE5E75AC5DC0Q33805632-52A26C68-4C73-43B4-88EE-29FB2CC0E472Q33849871-F9AA7EA5-9449-41B4-B057-E0B34EAAA84BQ33858302-95292DE4-0B74-4DCC-84AD-96CCD3067CA9Q33926928-FBE5023D-1A8D-40BF-9D99-DF5E7D0F3692Q33994883-CBEC8C34-EBCE-4A5C-8073-C9F454A4A8BCQ34066163-F51C652B-4F65-42B9-9742-C09E5C720C1CQ34359947-AE1E2525-8CC8-4C64-A671-1D16634F616EQ34440546-62D33EA5-EDA3-436C-AF44-75F853E13B2DQ34448791-CD1A80BC-BE8C-414A-8F6C-E38A857793E5Q34481804-4982558C-0A8F-4D95-8276-10BD846409D1Q34576595-D31C8998-3DBC-4B90-901B-5A7B736888E9Q35028826-E52AD671-44E9-4A64-A755-8012DE730462Q35148672-3C8ACB7C-95F8-45FF-95D8-36E9CEBD7747Q35369118-551DA985-8F77-4ACB-8E12-E86C42DBB4C5Q35819031-88734903-68BC-4220-A1CE-FBEA22C52A16
P2860
description
1989 nî lūn-bûn
@nan
1989 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
The cardiac effects of adenosine.
@ast
The cardiac effects of adenosine.
@en
type
label
The cardiac effects of adenosine.
@ast
The cardiac effects of adenosine.
@en
prefLabel
The cardiac effects of adenosine.
@ast
The cardiac effects of adenosine.
@en
P1476
The cardiac effects of adenosine.
@en
P2093
Belardinelli L
P356
10.1016/0033-0620(89)90015-7
P577
1989-07-01T00:00:00Z